Elisabetta Broseghini

602 total citations
23 papers, 389 citations indexed

About

Elisabetta Broseghini is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Elisabetta Broseghini has authored 23 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Elisabetta Broseghini's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (6 papers). Elisabetta Broseghini is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (6 papers). Elisabetta Broseghini collaborates with scholars based in Italy, United States and Australia. Elisabetta Broseghini's co-authors include Manuela Ferracin, Emi Dika, Mattia Riefolo, Martina Lambertini, Elena Campione, Federica Scarfì, Costantino Ricci, Emanuela Marcelli, Filippo Del Vecchio and Muller Fabbri and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Journal of Investigative Dermatology.

In The Last Decade

Elisabetta Broseghini

21 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Broseghini Italy 11 214 149 135 92 71 23 389
Emily A. Merkel United States 11 145 0.7× 49 0.3× 244 1.8× 51 0.6× 89 1.3× 17 340
Lucia Di Nardo Italy 10 206 1.0× 52 0.3× 167 1.2× 155 1.7× 181 2.5× 26 430
Chiara Astrua Italy 9 114 0.5× 44 0.3× 171 1.3× 35 0.4× 68 1.0× 22 322
Sasha D. Girouard United States 9 154 0.7× 40 0.3× 143 1.1× 70 0.8× 87 1.2× 10 315
Sarah J. Kurley United States 12 277 1.3× 45 0.3× 322 2.4× 161 1.8× 104 1.5× 25 514
Shinya Kitamura Japan 10 136 0.6× 32 0.2× 127 0.9× 76 0.8× 78 1.1× 55 333
Giulia Veronesi Italy 11 122 0.6× 39 0.3× 186 1.4× 60 0.7× 85 1.2× 58 367
Danielle M. Bello United States 12 145 0.7× 38 0.3× 401 3.0× 118 1.3× 74 1.0× 23 451
Siming Li China 9 282 1.3× 67 0.4× 403 3.0× 63 0.7× 55 0.8× 17 583
Sapna M. Amin United States 10 100 0.5× 45 0.3× 181 1.3× 57 0.6× 64 0.9× 22 302

Countries citing papers authored by Elisabetta Broseghini

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Broseghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Broseghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Broseghini more than expected).

Fields of papers citing papers by Elisabetta Broseghini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Broseghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Broseghini. The network helps show where Elisabetta Broseghini may publish in the future.

Co-authorship network of co-authors of Elisabetta Broseghini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Broseghini. A scholar is included among the top collaborators of Elisabetta Broseghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Broseghini. Elisabetta Broseghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Broseghini, Elisabetta, Costantino Ricci, Barbara Corti, et al.. (2025). Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases. Cancers. 17(13). 2253–2253.
2.
Broseghini, Elisabetta, et al.. (2025). Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers. Cancers. 17(4). 660–660. 1 indexed citations
3.
Broseghini, Elisabetta, et al.. (2025). Quantification of Tissue and Circulating MicroRNAs by Droplet Digital PCR. Methods in molecular biology. 2969. 195–233.
4.
Broseghini, Elisabetta, Giulia Gallerani, G. Siepe, et al.. (2025). Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers. Journal of Clinical Medicine. 14(4). 1170–1170. 3 indexed citations
5.
Broseghini, Elisabetta, Federico Venturi, Sabina Vaccari, et al.. (2024). Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas. Cancers. 16(9). 1688–1688. 5 indexed citations
6.
Broseghini, Elisabetta, Giulia Veronesi, Federico Venturi, et al.. (2024). Defining high-risk patients: beyond the 8the AJCC melanoma staging system. Archives of Dermatological Research. 317(1). 78–78. 1 indexed citations
7.
Broseghini, Elisabetta, Federico Venturi, Giulia Veronesi, et al.. (2024). Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer. Pigment Cell & Melanoma Research. 38(1). e13210–e13210. 1 indexed citations
8.
Broseghini, Elisabetta, et al.. (2024). Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives. Cancers. 16(15). 2752–2752. 15 indexed citations
9.
Broseghini, Elisabetta, et al.. (2023). Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Non-Coding RNA. 9(1). 9–9. 9 indexed citations
10.
Broseghini, Elisabetta, et al.. (2023). A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need. Diagnostics. 13(8). 1492–1492. 6 indexed citations
11.
Broseghini, Elisabetta, Francesca Comito, Massimo Milani, et al.. (2022). Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer. Expert Review of Molecular Diagnostics. 22(3). 305–318. 22 indexed citations
12.
Dika, Emi, Elisabetta Broseghini, Elisa Porcellini, et al.. (2021). Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis. Cell Death and Disease. 12(5). 473–473. 26 indexed citations
13.
Broseghini, Elisabetta, Emi Dika, Eric Londin, & Manuela Ferracin. (2021). MicroRNA Isoforms Contribution to Melanoma Pathogenesis. Non-Coding RNA. 7(4). 63–63. 10 indexed citations
14.
Vecchio, Filippo Del, et al.. (2021). Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T‐cells and tumour cells. Journal of Extracellular Vesicles. 10(6). e12075–e12075. 45 indexed citations
15.
Vecchio, Filippo Del, et al.. (2021). Diverse roles of EV-RNA in cancer progression. Seminars in Cancer Biology. 75. 127–135. 21 indexed citations
16.
Chin, Andrew R., Javier Mariscal, Minhyung Kim, et al.. (2021). miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles. Cancers. 13(22). 5850–5850. 5 indexed citations
17.
Comito, Francesca, et al.. (2021). Non-coding RNA dysregulation in skin cancers. Essays in Biochemistry. 65(4). 641–655. 18 indexed citations
18.
Dika, Emi, Mattia Riefolo, Elisa Porcellini, et al.. (2020). Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma. Journal of Investigative Dermatology. 140(11). 2260–2267. 22 indexed citations
19.
Gulei, Diana, Lajos Ráduly, Elisabetta Broseghini, Manuela Ferracin, & Ioana Berindan‐Neagoe. (2019). The extensive role of miR-155 in malignant and non-malignant diseases. Molecular Aspects of Medicine. 70. 33–56. 36 indexed citations
20.
Pagotto, Sara, Elisa Porcellini, Maria Giulia Bacalini, et al.. (2018). Abstract 3313: Epigenetic biomarkers of prognosis in stage IIA colon cancer. Cancer Research. 78(13_Supplement). 3313–3313. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily A. Merkel Breakdown of academic impact, for papers by Lucia Di Nardo Breakdown of academic impact, for papers by Chiara Astrua Breakdown of academic impact, for papers by Sasha D. Girouard Breakdown of academic impact, for papers by Sarah J. Kurley Breakdown of academic impact, for papers by Shinya Kitamura Breakdown of academic impact, for papers by Giulia Veronesi Breakdown of academic impact, for papers by Danielle M. Bello Breakdown of academic impact, for papers by Siming Li Breakdown of academic impact, for papers by Sapna M. Amin
Rankless by CCL
2026